Detalhe da pesquisa
1.
Self-Cascade Nanozyme Reactor as a Cuproptosis Inducer Synergistic Inhibition of Cellular Respiration Boosting Radioimmunotherapy.
Small
; : e2306263, 2024 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38221757
2.
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway.
Cancer Cell Int
; 24(1): 85, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402166
3.
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives.
Int J Mol Sci
; 25(10)2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791529
4.
Comprehensive analysis of the exosomal circRNA-miRNA-mRNA network in breast cancer.
J Gene Med
; 25(7): e3500, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942488
5.
Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial.
BMC Med
; 21(1): 226, 2023 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365596
6.
Dual-target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP-ribose) polymerase (PARP-1) and enhancing DNA damage.
Bioorg Chem
; 133: 106354, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720184
7.
Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFRWT human lung cancer.
Bioorg Chem
; 135: 106499, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058978
8.
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Cancer Cell Int
; 22(1): 67, 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139863
9.
Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
BMC Gastroenterol
; 22(1): 450, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344926
10.
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Cell Physiol Biochem
; 50(4): 1332-1345, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355943
11.
Poor-prognosis disclosure preference in cancer patient-caregiver dyads and its association with their quality of life and perceived stress: a cross-sectional survey in mainland China.
Psychooncology
; 25(9): 1099-105, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643744
12.
Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
Mol Carcinog
; 54(6): 449-58, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302553
13.
A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2).
Tumour Biol
; 36(7): 5179-86, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25652470
14.
A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice.
Tumour Biol
; 36(4): 2929-36, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25492485
15.
HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC).
BMC Cancer
; 14: 501, 2014 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25008389
16.
Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.
Pharmaceuticals (Basel)
; 17(5)2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38794221
17.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Nat Med
; 30(1): 249-256, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191615
18.
MiR-21 mediates the radiation resistance of glioblastoma cells by regulating PDCD4 and hMSH2.
J Huazhong Univ Sci Technolog Med Sci
; 33(4): 525-529, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904372
19.
The History and Development of HER2 Inhibitors.
Pharmaceuticals (Basel)
; 16(10)2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37895921
20.
Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer.
Front Oncol
; 13: 1098357, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726381